| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120.311 | 245.717 | 257.076 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120.311 | 245.718 | 257.079 |
| Total Expenses - EUR | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 86.914 | 135.407 | 154.149 |
| Gross Profit/Loss - EUR | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 33.397 | 110.311 | 102.929 |
| Net Profit/Loss - EUR | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 32.218 | 107.903 | 95.600 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 9 |
Check the financial reports for the company - Centrul De Cercetare Si Diagnostic Artemis Therapy
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.552 | 118.509 | 115.022 |
| Current Assets | 56 | 55 | 55 | 54 | 52 | 51 | 50 | 16.159 | 48.739 | 33.292 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.056 | 323 | 322 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.615 | 39.123 | 9.652 |
| Cash | 56 | 55 | 55 | 54 | 52 | 51 | 50 | 2.489 | 9.293 | 23.319 |
| Shareholders Funds | -223 | -221 | -217 | -213 | -209 | -205 | -200 | 32.017 | 129.493 | 113.197 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 279 | 276 | 271 | 266 | 261 | 256 | 251 | 42.695 | 37.755 | 35.116 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Centrul De Cercetare Si Diagnostic Artemis Therapy S.r.l.